Health
Australia signs agreement for new Covid-19 drug – Pharmaceutical Business Review
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths…
Australia has signed an agreement for 300,000 courses of molnupiravir, an antiviral pill that has shown signs of reducing deaths and hospitalisations due to Covid-19.
Being trialled in the US, this drug is yet to gain approval from the regulatory authorities.
…
Continue Reading
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
General22 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland